Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
18%

OVERLAP
BY WEIGHT
15

# OF OVERLAPPING
HOLDINGS
SBIO
84
HOLDINGS
18%
ALSO IN XPH
XPH
58
HOLDINGS
26%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XPH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in XPH
Overlap
DEFINIUM THERAPEUTICS INC 2.3% 2.5% 2.3%
TARSUS PHARMACEUTICALS, INC. 2.2% 2.2% 2.2%
AMYLYX PHARMACEUTICALS, INC. 2.1% 3.8% 2.1%
EDGEWISE THERAPEUTICS, INC. 2.6% 2.0% 2.0%
MBX BIOSCIENCES INC 1.6% 3.0% 1.6%
SBIO Overweight Relative to XPH
CG ONCOLOGY, INC. 3.7%
TRAVERE THERAPEUTICS, INC. 3.4%
DIANTHUS THERAPEUTICS INC 3.3%
ORUKA THERAPEUTICS INC 3.1%
ACADIA PHARMACEUTICALS INC 2.7%
RELAY THERAPEUTICS, INC. 2.3%
DYNE THERAPEUTICS INC 2.2%
DENALI THERAPEUTICS INC. 2.0%
IDEAYA BIOSCIENCES, INC. 1.9%
CELLDEX THERAPEUTICS INC 1.7%
SBIO Underweight Relative to XPH
OMEROS CORP -2.8%
ENLIVEN THERAPEUTICS, INC. -2.4%
CORCEPT THERAPEUTICS INC -2.1%
ETON PHARMACEUTICALS, INC. -2.1%
PERRIGO CO -2.0%
TREVI THERAPEUTICS, INC. -1.9%
MERCK & CO. INC. -1.9%
OCULAR THERAPEUTIX INC -1.8%
BRISTOL-MYERS SQUIBB CO -1.8%
HARMONY BIOSCIENCES HOLDINGS, INC. -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY